Search Filters

Search Results

Found 1 results

510(k) Data Aggregation

    K Number
    K133552
    Manufacturer
    Date Cleared
    2014-02-07

    (80 days)

    Product Code
    Regulation Number
    870.1280
    Reference & Predicate Devices
    Why did this record match?
    Device Name :

    MAGELLAN ROBOTIC CATHETER 6FR (GUIDE AND LEADER), MAGELLAN ROBOTIC CATHETER 6FR ACCESSORY KIT

    AI/MLSaMDIVD (In Vitro Diagnostic)TherapeuticDiagnosticis PCCP AuthorizedThirdpartyExpeditedreview
    Intended Use

    The Hansen Medical Magellan Robotic Catheter 6Fr is intended to be used to facilitate navigation to anatomical targets in the peripheral vasculature and subsequently provide a conduit for manual placement of therapeutic devices.

    The Magellan Robotic Catheter 6Fr is intended to be used with the Hansen Medical Magellan Robotic System and accessories.

    Device Description

    The Magellan Robotic Catheter 6Fr (MRC 6Fr) and accessories are a modification of the predicate Magellan Robotic Catheter 9Fr (MRC 9Fr) and accessories cleared under K132369. The Magellan Robotic Catheter 6Fr is a smaller size catheter comprised of a Guide (Outer Catheter) with dual bend articulating sections (distal and proximal) paired with a non-articulating Leader (Inner Catheter). The device is provided in two lengths (60cm and 95cm). Like the predicate device, the MRC 6Fr is designed to be used with Hansen Medical Magellan Robotic System and is intended to facilitate navigation to anatomical targets in the peripheral vasculature and subsequently provide a conduit for manual placement of therapeutic devices. The MRC 6Fr may also be used for delivery of diagnostic contrast agents. The device is provided sterile and is intended for single use only. The catheter is designed to expand Hansen Medical's market offering of compatible devices available for use with the Magellan Robotic System cleared under K132369.

    AI/ML Overview

    The provided text describes a 510(k) summary for the Hansen Medical Magellan Robotic Catheter 6Fr. It is a submission for a modified device, primarily focusing on its substantial equivalence to a predicate device (Magellan Robotic Catheter 9Fr).

    Therefore, the acceptance criteria and study information pertain to demonstrating this substantial equivalence through non-clinical testing.

    Here's the breakdown of the information requested, based on the provided text:

    1. A table of acceptance criteria and the reported device performance

    The document states: "All of the pre-determined acceptance criteria were met." However, it does not explicitly list the quantitative acceptance criteria for each test or the specific numerical performance results. It only lists the types of tests performed.

    Test CategoryAcceptance CriteriaReported Device Performance
    Material & Physical Properties(Not explicitly stated, but implied to be within acceptable ranges for safety and function)All pre-determined acceptance criteria were met.
    Visual and Dimensional(Not explicitly stated)Met.
    Pressure Leak Testing(Not explicitly stated)Met.
    Vacuum Testing(Not explicitly stated)Met.
    Tensile Strength Testing(Not explicitly stated)Met.
    Flush Testing(Not explicitly stated)Met.
    Articulation/Bending Stiffness Testing(Not explicitly stated)Met.
    Fatigue Testing(Not explicitly stated)Met.
    Guidewire Testing(Not explicitly stated)Met.
    Simulated Use Testing(Not explicitly stated)Met.
    Biocompatibility Testing(According to ISO10993-1 standards)Determined to be biocompatible. All pre-determined acceptance criteria were met.
    ISO MEM Elution Cytotoxicity Test(Not explicitly stated for specific test, but aligned with ISO 10993-1)Met.
    ISO Kligman Maximization Test(Not explicitly stated for specific test, but aligned with ISO 10993-1)Met.
    ISO Intracutaneous Reactivity Study(Not explicitly stated for specific test, but aligned with ISO 10993-1)Met.
    ISO Acute Systemic Toxicity Study(Not explicitly stated for specific test, but aligned with ISO 10993-1)Met.
    ASTM Hemolysis(Not explicitly stated for specific test, but aligned with ISO 10993-1)Met.
    ISO Thrombogenicity Study(Not explicitly stated for specific test, but aligned with ISO 10993-1)Met.
    Prothrombin Time (PT) Assay ISO(Not explicitly stated for specific test, but aligned with ISO 10993-1)Met.
    ISO Complement Activation Assay(Not explicitly stated for specific test, but aligned with ISO 10993-1)Met.

    2. Sample size used for the test set and the data provenance (e.g. country of origin of the data, retrospective or prospective)

    The document does not specify the sample sizes used for any of the non-clinical tests. It also does not provide information on the country of origin of the data or whether the data was retrospective or prospective. Given these are non-clinical (bench and lab) tests, these details are typically less relevant than for clinical studies.

    3. Number of experts used to establish the ground truth for the test set and the qualifications of those experts (e.g. radiologist with 10 years of experience)

    This information is not applicable and not provided. The study performed consists of non-clinical, benchtop and lab-based engineering, and biocompatibility tests, not clinical studies requiring expert ground truth for interpretation.

    4. Adjudication method (e.g. 2+1, 3+1, none) for the test set

    This information is not applicable and not provided. As noted above, the study involved non-clinical tests, which do not typically involve adjudication methods for "ground truth" in the way clinical diagnostic image interpretation studies would. The "ground truth" for these tests would be the established scientific and engineering standards and methods.

    5. If a multi reader multi case (MRMC) comparative effectiveness study was done, If so, what was the effect size of how much human readers improve with AI vs without AI assistance

    No MRMC comparative effectiveness study was done. The document explicitly states: "Clinical evaluation is not required for this device." This is a submission for a modified steerable catheter, demonstrating substantial equivalence through non-clinical testing.

    6. If a standalone (i.e. algorithm only without human-in-the-loop performance) was done

    This information is not applicable. The device is a robotic catheter, not an algorithm or AI system for diagnostic interpretation that would have "standalone" performance in the context of diagnostic accuracy. The performance testing described is for the physical and biological characteristics of the catheter itself.

    7. The type of ground truth used (expert consensus, pathology, outcomes data, etc)

    The "ground truth" for the non-clinical tests described would be the established scientific and engineering principles, specifications, and regulatory standards to which the device was tested. For example, for biocompatibility, the ground truth is defined by ISO 10993-1, and for physical tests, it's defined by engineering specifications and industry standards for catheter performance (e.g., specific thresholds for tensile strength, leak rates, articulation angles, etc.). These are not "expert consensus" or "pathology" in the diagnostic sense.

    8. The sample size for the training set

    This information is not applicable and not provided. This device is a physical medical device (catheter) and not an AI/ML algorithm that requires a "training set."

    9. How the ground truth for the training set was established

    This information is not applicable and not provided for the same reasons as point 8.

    Ask a Question

    Ask a specific question about this device

    Page 1 of 1